The IT+CsA combination was examined in a number of cell lines of different cancer types: cervical HeLa*, breast T47D and MA11, prostate DU145, glioblastoma D54MG (all with mutated p53), and glioblastoma U87MG (with wild-type p53). This evidence concerns the gene TP53 and cancer.